v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenues, net $ 22,442 $ 22,423
Cost of revenues 15,503 14,380
Gross profit 6,939 8,043
Operating expense:    
General and administrative 8,351 7,576
Depreciation and amortization 2,556 2,463
Research and development 936 912
Total operating expense 11,843 10,951
Loss from operations (4,904) (2,908)
Other (expense) income:    
Interest expense, net (1,274) (2,487)
Other income (expense), net (700) 653
Loss on warrant issuance 0 (578)
Change in fair value of derivative liabilities (32) (9)
Change in fair value of common warrants 0 1,936
Total other expense (2,006) (485)
Loss before income taxes (6,910) (3,393)
Income tax benefit (expense) 385 150
Net loss (6,525) (3,243)
Fixed dividends - Series B Preferred (317) (317)
Net loss attributable to common stockholders - basic (6,842) (3,560)
Net loss attributable to common stockholders - diluted (6,842) (3,560)
Comprehensive loss:    
Net loss (6,525) (3,243)
Other comprehensive income (loss):    
Foreign currency translation adjustment (138) 570
Total comprehensive loss $ (6,663) $ (2,673)
Net loss per share of Class A common stock – basic (in dollars per share) $ (2.25) $ (8.45)
Net loss per share of Class A common stock - diluted (in dollars per share) $ (2.25) $ (8.45)
Weighted average number of shares of Class A common stock outstanding – basic (in shares) 3,038,178 421,541
Weighted average number of shares of Class A common stock outstanding – diluted (in shares) 3,038,178 421,541